MIM Software inks deal with Videra Surgical
April 5, 2022 -- MIM Software and oncology surgery company Videra Surgical are teaming up on a new partnership involving breast cancer radiation therapy. Read More
Radiaction receives FDA clearance for radiation shield system
April 1, 2022 -- Radiaction Medical recently received 510(K) clearance from the U.S. Food and Drug Administration (FDA) to market its Shield System in the U.S. Read More
ITM promotes supply deal with Novartis for Pluvicto
March 25, 2022 -- German radiopharmaceutical firm ITM Isotope Technologies Munich SE (ITM) highlighted its lutetium-177 supply deal with Novartis in the wake of the U.S. Food and Drug Administration's approval of the company's Pluvicto radioligand therapy. Read More
Clarity launching trial for prostate cancer therapy
March 24, 2022 -- Clarity Pharmaceuticals is launching an investigator-initiated trial that will focus on the use of its copper-64 (Cu-64)-labeled radiopharmaceutical, Cu-64 SAR-bisPSMA, in prostate cancer. Read More
Eckert & Ziegler partners with Alpha-9 Theranostics
March 23, 2022 -- Isotope technology firm Eckert & Ziegler has agreed to supply lutetium-177 to the Canadian biotechnology firm Alpha-9 Theranostics for use in clinical trials. Read More
Navidea reports revenue declines in Q4, all of 2021
March 23, 2022 -- Radiopharmaceutical developer Navidea Biopharmaceuticals reported a decline in revenues for the fourth quarter of 2021 and the entire year. Read More
FluoGuide gives details on brain cancer research in Denmark
March 18, 2022 -- FluoGuide said a research grant connected to its work with Rigshospitalet in Copenhagen, Denmark, will help it set up a phase II trial for the company's FG001 radiopharmaceutical candidate in patients with less aggressive brain cancers. Read More
Dutch isotope reactor restarts
March 17, 2022 -- The High Flux Reactor (HFR) in Petten, the Netherlands, has restarted after a forced shutdown due to a water leak in January, with isotopes deliveries to hospitals expected within two weeks. Read More
IBA and Tractebel partner on construction projects
March 15, 2022 -- Proton therapy developer Ion Beam Applications (IBA) has inked a partnership agreement with engineering company Tractebel to support IBA's customers with their proton therapy design and construction projects. Read More
Viewray achieves milestone with MRIdian rad therapy
March 15, 2022 -- Image-guided radiation therapy developer ViewRay is reporting a milestone achieved by a user in Italy of its MRIdian MRI-guided radiation therapy system. Read More
Special Feature
Representation in radiation oncology remains challenging

Radiation oncology has some of the lowest numbers when it comes to female senior faculty representation, according to research published in JAMA Network Open. Read more